Remove Injections Remove Safety Remove Therapy
article thumbnail

Exosomes vs PRP: Transform Your Skin Care Routine

Kim Gallo Esthetics

Two groundbreaking treatments making waves are Exosomes and Platelet-Rich Plasma (PRP) therapies. What is Platelet-Rich Plasma (PRP) Therapy? How PRP Works Once the platelets are isolated, they are injected into the skin, where they release growth factors that encourage collagen production and tissue regeneration.

article thumbnail

Understanding the Distinction: PRF vs. PRP in Facial Injectable Industry

AAFE - American Academy of Facial Esthetics

In this comprehensive guide, we delve into the dissimilarities between PRF and PRP and explore their respective benefits within the facial injectable industry. Platelet-Rich Fibrin (PRF): In contrast, Platelet-Rich Fibrin (PRF) represents a more advanced form of platelet therapy.

article thumbnail

Otezla Now Available for Kids With Moderate to Severe Psoriasis

The Dermatology Digest

Food and Drug Administration (FDA) approved apremilast for the treatment of moderate to severe plaque psoriasis in children and adolescents ages 6 and older who weigh at least 20 kg (44 lb) and are candidates for phototherapy or systemic therapy. The adverse events were consistent with the known safety profile of Otezla in adult patients.

Safety 74
article thumbnail

Exploring Oral Options for Psoriasis Therapies

US Dermatologt Partners

In the ever-evolving landscape of psoriasis treatment, oral therapies continue to play a crucial role. 2 Newer Generation Oral Therapies “We live in an exciting time because we’ve got new topical therapies, multiple oral therapies, and obviously, an array of biologic agents and patient preferences change,” Lockshin said.

Therapy 41
article thumbnail

The Importance of Hands-On Training in Aesthetic Medicine

AAAMS

Aesthetic medicine is a rapidly growing field, with demand for non-invasive and minimally invasive procedures like Botox, dermal fillers, and laser therapies surging. The Role of Hands-On Training in Patient Safety In aesthetic medicine, patient safety is paramount. How does hands-on training improve patient safety?

article thumbnail

FDA Accepts sBLA for UCB’s Bimzelx in Moderate-to-Severe HS and Additional 2mL Device Presentations

The Dermatology Digest

Today, one dose of Bimzelx in moderate-to-severe plaque psoriasis is administered as two 1mL injections. Approval of the 2mL device presentations would mean that patients would have an alternative one-injection regimen option,” Caeymaex says. In addition, improvements increased for patients in these studies over 48 weeks. In the U.S.,

Safety 57
article thumbnail

More Breaking News: U.S. FDA Approves Nemolizumab (Nemluvio, Galderma) for Patients with Moderate to Severe AD

The Dermatology Digest

Food and Drug Administration (FDA) has approved nemolizumab (Nemluvio, Galderma) for the treatment of patients aged 12 and older with moderate to severe atopic dermatitis, in combination with topical corticosteroids (TCS) and/or calcineurin inhibitors (TCI) when the disease is not adequately controlled with topical prescription therapies.